AR aberrations and resistance to abiraterone or enzalutamide
Tools
Attard, G., Antonarakis, E. S.
(2016)
AR aberrations and resistance to abiraterone or enzalutamide.
NATURE REVIEWS UROLOGY, 13 (12).
pp. 697-698.
ISSN 1759-4812
Full text not available from this repository.
Abstract
Resistance to abiraterone or enzalutamide is a major medical burden the duration of benefit is highly variable and cross-resistance often occurs when these two agents are given sequentially. Blood-based analysis of androgen receptor splice variants and AR copy number gain or mutations could enhance understanding of the mechanisms of resistance and improve management of patients with castration-resistant prostate cancer.
Item Type: | Editorial |
---|---|
Authors (ICR Faculty only): | Attard, Gert |
All Authors: | Attard, G., Antonarakis, E. S. |
Additional Information: | ISI Document Delivery No.: EE9SL Times Cited: 0 Cited Reference Count: 10 Attard, Gerhardt Antonarakis, Emmanuel S. 0 NATURE PUBLISHING GROUP NEW YORK NAT REV UROL |
Research teams: | ICR divisions > Molecular Pathology > Treatment Resistance |
Depositing User: | Barry Jenkins |
Date Deposited: | 10 Jan 2017 09:31 |
Last Modified: | 10 Jan 2017 09:31 |
URI: | http://publications.icr.ac.uk/id/eprint/15606 |
Actions (login required)
![]() |
View Item |